PharmaSeq, Inc.

DNA analysis, Proteomics, combinatorial chemistry, SNP detection, combinatorial chemistry, radio frequency identification

PharmaSeq, Inc. is a privately held start-up biotechnology company founded by Wlodek Mandecki in 1997.

Richard G. Morris (CEO)
Wlodek Mandecki (President)

Wlodek Mandecki (Chairman)
Zbigniew Darzynkiewicz
David Freedman
Richard G. Morris

Zbigniew Darzynkiewicz
Robert Patti
Peter Tolias
Edward Cox
Robert Patti
Peter Tolias

11 Deer Park Drive, Suite 104
Monmouth Junction, NJ 08852
USA
Phone: +1-732-355-0100
Fax: +1-732-355-0102

The Microtransponder is a light-powered micro-/nanotransponder for performing nucleic-acid based assays. The transponders are tiny silicon integrated circuits that transmit radio signals when activated by light. An oligo probe is attached to each transponder, a vial of tagged transponders is hybridised to a sample solution. Detection of hybridisation: the particles are shot rapidly through a tube and individually zapped with a light beam and tag ID is matched with sequence ID using a computer that is attached to the detection system.